Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-023072
Filing Date
2026-03-03
Accepted
2026-03-03 21:35:40
Documents
1
Period of Report
2026-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm267953-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm267953-3_4seq1.xml 4 12197
  Complete submission text file 0001104659-26-023072.txt   13618
Mailing Address 21 FIRSTFIELD RD GAITHERSBURG MD
Business Address 21 FIRSTFIELD RD GAITHERSBURG MD 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Kelly James Patrick (Reporting) CIK: 0001506314 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 26718642